Endologix Inc. Reports 12% Global Revenue Growth For The First Quarter 2014
IRVINE, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three months ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.